CANNASSURE THERAPEUTICS LTD

Highlights Cannassure Therapeutics Ltd

Equities

CSURE-M

IL0001110134

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:54:26 08/05/2024 pm IST			5-day change	1st Jan Change
1,511 ^ILa	+0.73%		+13.52%	+212.84%

27/03	Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Cannassure Therapeutics Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Cannassure Therapeutics Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Cannassure Was Granted A Patent for an Oral Delivery Method of Cannabis and Cannabinoids Compositions by the Israel Patents Authority	09/21/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW